Latest Period
Q1 2026
Security Snapshot
Xtant Medical Holdings, Inc. - Common Stock (XTNT) Institutional Ownership
CUSIP: 98420P308
13F Institutional Holders and Ownership History from Q1 2018 to Q2 2026
Institutions Reporting
34
Shares (Excl. Options)
80,736,006
Price
$0.56
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- XTNT on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 80,736,006
- Total 13F value
- $45,051,748
- Portfolio coverage rank
- 0%
- Share change
- -668,739
- Value change
- -$391,346
- Number of holders
- 34
- Shares outstanding
- 140,036,400
- SEC-reported price per share
- $0.42
- Insider filing price
- $0.42
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- XTNT - Xtant Medical Holdings, Inc. - Common Stock is tracked under CUSIP 98420P308.
- 34 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 34 to 1 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $45,051,748 to $842.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 34 institutions filings for Q1 2026.
Security key
98420P308
Latest holder period
Q1 2026
13F holders
34
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
XTNT full holder history
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Xtant Medical Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 98420P308:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
XTNT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 49% | 0% | $50,543,166 | 68,394,000 | 0% | Nantahala Capital Management, LLC | 01 Aug 2025 | |
| LYTTON LAURENCE W | 5.5% | -19% | $5,545,441 | -$1,268,237 | 7,702,002 | -19% | LYTTON LAURENCE W | 31 Dec 2025 |
As of 31 Mar 2026, 34 institutional investors reported holding 80,736,006 shares of Xtant Medical Holdings, Inc. - Common Stock (XTNT). This represents 58% of the company’s total 140,036,400 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
58%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 49% | 68,394,000 | 0% | 2.4% | $38,163,852 |
| AWM Investment Company, Inc. | 4.3% | 5,976,910 | -9.4% | 0.37% | $3,335,116 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.4% | 2,014,603 | 0% | 0% | $1,124,148 |
| RENAISSANCE TECHNOLOGIES LLC | 0.71% | 987,410 | +7.3% | 0% | $550,975 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.38% | 529,214 | +7.6% | 0% | $295,376 |
| Crescent Grove Advisors, LLC | 0.29% | 412,024 | 0% | 0.02% | $229,909 |
| Hillsdale Investment Management Inc. | 0.26% | 362,200 | 0% | 0.01% | $202,108 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 0.25% | 350,000 | +25% | 0.18% | $195,300 |
| VANGUARD FIDUCIARY TRUST CO | 0.18% | 257,988 | 0% | 0% | $143,957 |
| ACADIAN ASSET MANAGEMENT LLC | 0.13% | 180,299 | -7.1% | 0% | $99,000 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.12% | 164,100 | 0% | 0% | $91,568 |
| CITADEL ADVISORS LLC | 0.11% | 161,011 | -44% | 0% | $89,844 |
| MILLENNIUM MANAGEMENT LLC | 0.09% | 132,354 | -31% | 0% | $73,854 |
| BlackRock, Inc. | 0.08% | 115,782 | 0% | 0% | $64,606 |
| Mink Brook Asset Management LLC | 0.08% | 109,466 | 0% | 0.03% | $61,082 |
| WIREGRASS INVESTMENT MANAGEMENT LLC | 0.07% | 103,000 | 0% | 0.05% | $57,474 |
| Tradition Wealth Management, LLC | 0.07% | 100,297 | 0% | 0% | $55,966 |
| NORTHERN TRUST CORP | 0.07% | 99,598 | +73% | 0% | $55,576 |
| Private Advisor Group, LLC | 0.06% | 85,000 | 0% | 0% | $47,430 |
| XTX Topco Ltd | 0.03% | 37,933 | 0% | $21,167 | |
| JANE STREET GROUP, LLC | 0.02% | 33,978 | +77% | 0% | $18,960 |
| STATE STREET CORP | 0.02% | 31,266 | 0% | 0% | $17,446 |
| SEI INVESTMENTS CO | 0.02% | 24,760 | 0% | $13,816 | |
| Kestra Advisory Services, LLC | 0.01% | 20,000 | 0% | 0% | $11,160 |
| LAZARD ASSET MANAGEMENT LLC | 0.01% | 19,562 | -14% | 0% | $10,916 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
34
Latest
Q1 2026
Rows shown
1-25 of 34
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 2,000 | $842 | $0.42 | 1 | |
| 2026 Q1 | 80,736,006 | $45,051,748 | -$391,346 | $0.56 | 34 |
| 2025 Q4 | 81,404,745 | $63,818,481 | +$760,014 | $0.78 | 35 |
| 2025 Q3 | 80,064,653 | $51,958,020 | +$59,666 | $0.65 | 29 |
| 2025 Q2 | 79,963,210 | $59,092,411 | +$9,527,080 | $0.74 | 29 |
| 2025 Q1 | 96,332,001 | $45,274,819 | -$166,227 | $0.47 | 26 |
| 2024 Q4 | 96,692,530 | $42,834,946 | -$1,064,038 | $0.44 | 28 |
| 2024 Q3 | 98,215,048 | $66,126,833 | +$5,325,340 | $0.68 | 27 |
| 2024 Q2 | 90,066,890 | $56,742,224 | -$435,632 | $0.63 | 26 |
| 2024 Q1 | 90,374,385 | $105,738,087 | +$205,479 | $1.17 | 33 |
| 2023 Q4 | 90,202,353 | $101,928,562 | -$82,302 | $1.13 | 31 |
| 2023 Q3 | 90,276,097 | $99,304,130 | +$9,366,353 | $1.10 | 28 |
| 2023 Q2 | 81,765,290 | $76,033,381 | -$53,515 | $0.93 | 19 |
| 2023 Q1 | 81,854,114 | $52,181,371 | -$34,628 | $0.64 | 21 |
| 2022 Q4 | 81,903,507 | $54,055,554 | +$144,724 | $0.66 | 19 |
| 2022 Q3 | 81,682,735 | $58,794,209 | +$779,674 | $0.72 | 12 |
| 2022 Q2 | 80,613,065 | $41,878,151 | +$4,656 | $0.52 | 12 |
| 2022 Q1 | 80,534,844 | $54,787,198 | -$46,947 | $0.68 | 15 |
| 2021 Q4 | 80,663,007 | $45,172,000 | +$87,373 | $0.56 | 17 |
| 2021 Q3 | 80,508,571 | $89,363,000 | -$2,471,600 | $1.11 | 12 |
| 2021 Q2 | 82,710,575 | $134,818,000 | +$13,336,837 | $1.63 | 14 |
| 2021 Q1 | 74,502,096 | $175,824,000 | +$1,768,228 | $2.36 | 14 |
| 2020 Q4 | 73,761,114 | $88,226,000 | +$76,215,399 | $1.20 | 11 |
| 2020 Q3 | 10,131,401 | $8,345,000 | -$186,747 | $0.82 | 12 |
| 2020 Q2 | 10,345,548 | $9,310,000 | -$902,433 | $0.90 | 10 |